Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

41 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Simultaneous ALS and SCA2 associated with an intermediate-length ATXN2 CAG-repeat expansion.
Ghahremani Nezhad H, Franklin JP, Alix JJP, Moll T, Pattrick M, Cooper-Knock J, Shanmugarajah P, Beauchamp NJ, Hadjivissiliou M, Paling D, Mcdermott C, Shaw PJ, Jenkins TM. Ghahremani Nezhad H, et al. Among authors: paling d. Amyotroph Lateral Scler Frontotemporal Degener. 2021 Nov;22(7-8):579-582. doi: 10.1080/21678421.2020.1853172. Epub 2020 Dec 7. Amyotroph Lateral Scler Frontotemporal Degener. 2021. PMID: 33284045 Free article.
Is a Wearable Sensor-Based Characterisation of Gait Robust Enough to Overcome Differences Between Measurement Protocols? A Multi-Centric Pragmatic Study in Patients with Multiple Sclerosis.
Angelini L, Carpinella I, Cattaneo D, Ferrarin M, Gervasoni E, Sharrack B, Paling D, Nair KPS, Mazzà C. Angelini L, et al. Among authors: paling d. Sensors (Basel). 2019 Dec 21;20(1):79. doi: 10.3390/s20010079. Sensors (Basel). 2019. PMID: 31877760 Free PMC article.
The four self-efficacy trajectories among people with multiple sclerosis: Clinical associations and implications.
Young CA, Mills R, Langdon D, Sharrack B, Majeed T, Kalra S, Footitt D, Rog D, Harrower T, Nicholas R, Woolmore J, Thorpe J, Hanemann CO, Ford H, Paling D, Ellis C, Palace J, Constantinescu C, Tennant A. Young CA, et al. Among authors: paling d. J Neurol Sci. 2022 May 15;436:120188. doi: 10.1016/j.jns.2022.120188. Epub 2022 Feb 18. J Neurol Sci. 2022. PMID: 35303502
Optic neuritis as presenting primary hypoparathyroidism.
Arshad MF, Karim R, Paling D, Jayamanne G. Arshad MF, et al. Among authors: paling d. BMJ Case Rep. 2018 Nov 28;11(1):e227032. doi: 10.1136/bcr-2018-227032. BMJ Case Rep. 2018. PMID: 30567123 Free PMC article.
COVID-19 in Multiple Sclerosis: Clinically reported outcomes from the UK Multiple Sclerosis Register.
Middleton RM, Craig EM, Rodgers WJ, Tuite-Dalton K, Garjani A, Evangelou N, das Nair R, Hunter R, Tallantyre EC, Cauchi M, Cairn C, Paling D, Fuller S, McDonnell G, Petheram K, Liu B, Nock U, Ingram G, Brownlee W, Taylor J, Nicholas R; UK Multiple Sclerosis Register Research Group. Middleton RM, et al. Among authors: paling d. Mult Scler Relat Disord. 2021 Nov;56:103317. doi: 10.1016/j.msard.2021.103317. Epub 2021 Oct 8. Mult Scler Relat Disord. 2021. PMID: 34653949 Free article.
Fatigue in multiple sclerosis: A UK MS-register based study.
Moore H, Nair KPS, Baster K, Middleton R, Paling D, Sharrack B. Moore H, et al. Among authors: paling d. Mult Scler Relat Disord. 2022 Aug;64:103954. doi: 10.1016/j.msard.2022.103954. Epub 2022 Jun 7. Mult Scler Relat Disord. 2022. PMID: 35716477 Free article.
Phenytoin for neuroprotection in patients with acute optic neuritis: a randomised, placebo-controlled, phase 2 trial.
Raftopoulos R, Hickman SJ, Toosy A, Sharrack B, Mallik S, Paling D, Altmann DR, Yiannakas MC, Malladi P, Sheridan R, Sarrigiannis PG, Hoggard N, Koltzenburg M, Gandini Wheeler-Kingshott CA, Schmierer K, Giovannoni G, Miller DH, Kapoor R. Raftopoulos R, et al. Among authors: paling d. Lancet Neurol. 2016 Mar;15(3):259-69. doi: 10.1016/S1474-4422(16)00004-1. Epub 2016 Jan 26. Lancet Neurol. 2016. PMID: 26822749 Clinical Trial.
41 results